Article

Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy Benefit

2025-05-15

Abstract excerpt

Genomic testing has transformed treatment decisions for hormone receptor-positive, HER2-negative (HR+/HER2-) early breast cancer; however, it remains inaccessible to many patients worldwide due to high costs and logistical barriers. Here, we developed an artificial intelligence (AI) model using a multimodal deep learning approach that estimates Oncotype DX 21-gene recurrence scores (RS) from routine histopathology...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 48c63760-047a-5195-8b36-1dc3c026d1c7
DOI: 10.1101/2025.05.15.25327686

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitDOI 10.1101/2025.05.15.25327686Read

Prediction of OncotypeDX recurrence score using H&E stained WSI imagesSemantic proximity Read

Deep learning from HE slides to predict the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancerSemantic proximity Read

Multimodal Prediction of Breast Cancer Recurrence Assays and Risk of RecurrenceSemantic proximity Read

Assessing the risk of recurrence in early-stage breast cancer through H&E stained whole slide imagesSemantic proximity Read

Multimodal histopathologic models stratify hormone receptor-positive early breast cancerSemantic proximity Read

Clinical Validation of RlapsRisk BC in an international multi-cohorts settingSemantic proximity Read

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceSemantic proximity Read

MRI-based Prognostic Model in Early-Stage HR+/HER2- Breast CancerSemantic proximity Read

HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancerSemantic proximity Read

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assaySemantic proximity Read

Prognostic Risk Refinement using Artificial Intelligence in HR+/HER2- Early Breast Cancer: Implications for CDK4/6 Eligibility CriteriaSemantic proximity Read

Predicting MammaPrint Recurrence Risk from Breast Cancer Pathological Images Using a Weakly Supervised TransformerSemantic proximity Read